Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 10, Number 9, September 2018, pages 688-692


Vulvovestibular Syndrome and Vaginal Microbiome: A Simple Evaluation

Figure

Figure 1.
Figure 1. Comparison of bacterial population in the studied clinical cases. The value is expressed in CFU/mL ± SD.

Tables

Table 1. Patient’s Characteristics
 
PatientsControls
No. of patients5050
Mean age (years ± SD)33.6 ± 2.7530.5 ± 3.12
Mean weight (kg ± SD)57.5 ± 5.1155.8 ± 3.19
Mean height (cm ± SD)162 ± 5.97157 ± 3.44
Smokers1821
Currently in a stable relationship3227
Mean pain severity (± SD)7.1 ± 1.230
Electromiographic biofeedback (µV ± SD)127.8 ± 12.512.7 ± 8.1

 

Table 2. Inclusion and Exclusion Criteria of Enrolled Patients
 
Inclusion criteriaExclusion criteria
DyspareuniaPregnant or lactating women
Positive SWAB testOngoing antifungal, antibiotic or antiviral therapy
The hypertonia of anus elevator muscleOral contraceptives
Previous topical or systemic therapiesVaginal diazepam suppositories

 

Table 3. Bacterial Species in the Health Patients (Controls) and in VVS Patients
 
Bacterial speciesControls, mean ± SD (CFU/mL)VVS patients, mean ± SD (CFU/mL)Statistical relevance
Lactobacillus spp.236.00 ± 54.13158.69 ± 28.32P < 0.05
Klebsiella spp.35.40 ± 5.36174.03 ± 27.21P < 0.05
Candida spp.2.00 ± 1.4737.53 ± 6.71P < 0.05
Gardnerella spp.1.30 ± 1.201.11 ± 25.12P < 0.05
Streptococcus spp.1.35 ± 1.051.51 ± 29.31P < 0.05
Mycoplasma1.51 ± 1.111.42 ± 26.11P < 0.05
Fungi spp.25.60 ± 6.02230.13 ± 92.14P < 0.05